- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Litigation Support Services
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
-
April 16, 2021Ronald Schutz Named 2021 Lawdragon Legend
-
April 14, 2021Robins Kaplan Secures Asylum, Relative Petition for Somali Journalist
-
April 12, 2021Robins Kaplan Executives Recognized by Twin Cities Business
-
April 28, 2021Creating the Audit Clause for Today’s Compliance Review
-
April 29, 2021International Intellectual Property: Challenges of Cross-Border Litigation
-
April 29, 2021Breakthrough Greater Boston Reflections on Resilience Virtual Gala
-
April 13, 2021US Antitrust Regulators Should Foster Climate Collaboration
-
April 2, 2021Prepare For Minn. Privacy Law To Catch Up To Calif., Wash.
-
Spring 2021Fiduciary or Foe? Revisiting Meinhard v. Salmon
-
April 16, 2021Financial Daily Dose 4.16.2021 | Top Story: Lower Jobless Claims and Big U.S. Retail Sales Power Dow Above 34,000
-
April 15, 2021Financial Daily Dose 4.15.2021 | Top Story: Big Banks Deliver Huge Q1 Profits, Economic Optimism Despite Ongoing Challenges
-
April 14, 2021Financial Daily Dose 4.14.2021 | Top Story: Crypto Exchange Coinbase Makes Public Debut on Nasdaq
Jamie R. Kurtz

Jamie R. Kurtz
Partner

Experience
Jamie is a trial attorney that primarily focuses her practice on intellectual property and heath care litigation. Jamie currently represents various healthcare plans in multi-million-dollar litigation with providers involving claims improper billing, breach of contract, and fraud. In the IP space, she has represented clients ranging from individual business owners to Fortune 500 companies in matters involving numerous technologies ranging from pharmaceuticals and medical devices MRI technology to windshield washer fluid. In all areas, Jamie uses her technical background to help clients develop their case and develop an appropriate strategy to achieve their business goals.
Jamie attended law school at the University of Minnesota, where she graduated magna cum laude. While in law school, Jamie also attended graduate school where she received her M.S. in Pharmacology. Jamie’s Master’s project was focused on studying the toxic effect of DNA-Protein crosslinks caused by various types of drugs.
PCT International Inc. v. Holland Electronics LLC. Represented plaintiff in a patent infringement case involving coaxial cable connector technology. Won a jury verdict of infringement in May of 2015.
Defense counsel for Upsher-Smith Laboratories in Auxilium Pharmaceuticals v. Upsher-Smith Laboratories, a Hatch-Waxman patent infringement case in which we obtained a summary judgment of non-infringement of ten patents claiming a transdermal testosterone gel and method of treating hypogonadism before Judge Sue Robinson of the Federal District Court in Delaware. The opinion was filed on December 4, 2013. The technology related to claimed macrocyclic penetration enhancers for increasing the rate of passage of an androgen through the skin. We were successful in demonstrating to the Court that the case warranted an exception to the Court’s ordinary practice of declining to hear summary judgment motions in Hatch-Waxman cases.
Wisconsin Alumni Research Foundation v. Siemens AG, et al. Represented the Wisconsin Alumni Research foundation in a case involving magnetic resonance imaging (MRI) technology. Settled for value.
Promega Corp. v. Applied Biosystems, LLC, et al. Represented Promega in a case involving DNA analysis technologies. Won summary judgment of invalidity of all asserted claims.
Forest Laboratories, Inc. v. Torrent Pharmaceuticals Ltd. Represented client in litigation to bring generic Bystolic® (nebivolol) to market. Settled for value.

- Named a "Rising Star," Law360 (2020)
- Named an "Associate to Watch," Chambers (2017)
- Named a "Minnesota Rising Star," Super Lawyers (2015-2020)
- Minnesota
- U.S. Court of Appeals, Federal Circuit
- U.S. Court of Appeals, Ninth Circuit
- U.S. District Court, Minnesota
- “Upsher-Smith Secures Summary Judgment Noninfringement Ruling on Testim Patents,” Bloomberg BNA Pharmaceutical Law & Industry Report, Vol. 11, No. 48 (December 13, 2013)
- A Practical Guide for Assessing and Responding to Potential Data Breach
10th Annual Advanced Forum on Managed Care Disputes and Litigation, Chicago, Illinois (May 17, 2019)
RESOURCES
PUBLICATIONS
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.